approval · primary record
DOLUTEGRAVIR
FDA · NDA · 2026-05-07
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-05-07 |
| Brand | DOLUTEGRAVIR, LAMIVUDINE and TENOFOVIR DISOPROXIL FUMARATE |
| Sponsor | ASPEN SA OPERATIONS (PTY) LTD |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:19.337Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DOLUTEGRAVIR:2026-05-07
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.